Glycomimetics Stock Analysis
| GLYC Stock | USD 0.32 0.01 3.03% |
GlycoMimetics is undervalued with Real Value of 1.61 and Target Price of 5.5. The main objective of GlycoMimetics stock analysis is to determine its intrinsic value, which is an estimate of what GlycoMimetics is worth, separate from its market price. There are two main types of GlycoMimetics' stock analysis: fundamental analysis and technical analysis.
The GlycoMimetics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GlycoMimetics' ongoing operational relationships across important fundamental and technical indicators.
GlycoMimetics |
GlycoMimetics Stock Analysis Notes
About 48.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. GlycoMimetics recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people. To learn more about GlycoMimetics call Rachel King at 240 243 1201 or check out https://www.glycomimetics.com.GlycoMimetics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GlycoMimetics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GlycoMimetics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GlycoMimetics is way too risky over 90 days horizon | |
| GlycoMimetics has some characteristics of a very speculative penny stock | |
| GlycoMimetics appears to be risky and price may revert if volatility continues | |
| GlycoMimetics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 10 K. Net Loss for the year was (36.9 M) with profit before overhead, payroll, taxes, and interest of 75 K. | |
| GlycoMimetics currently holds about 60.24 M in cash with (34.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| GlycoMimetics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: GlycoMimetics Q3 Earnings Snapshot |
GlycoMimetics Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GlycoMimetics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
GlycoMimetics Largest EPS Surprises
Earnings surprises can significantly impact GlycoMimetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-03-29 | 2022-12-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2022-08-03 | 2022-06-30 | -0.28 | -0.25 | 0.03 | 10 | ||
2018-11-02 | 2018-09-30 | -0.3 | -0.27 | 0.03 | 10 |
GlycoMimetics Stock Institutional Investors
| Shares | Two Sigma Advisers, Llc | 2024-06-30 | 108.8 K | Hcr Wealth Advisors | 2024-09-30 | 100 K | Sargent Investment Group, Llc | 2024-06-30 | 100 K | Gsa Capital Partners Llp | 2024-09-30 | 83.7 K | Ubs Group Ag | 2024-06-30 | 83 K | Bridgeway Capital Management, Llc | 2024-06-30 | 81.8 K | Group One Trading, Lp | 2024-06-30 | 65.4 K | Hrt Financial Llc | 2024-06-30 | 47.7 K | Intellectus Partners, Llc | 2024-09-30 | 46 K | Bvf Inc | 2024-09-30 | 9.5 M | Artal Group S A | 2024-06-30 | 8.6 M |
GlycoMimetics Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.63 M.GlycoMimetics Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.81) | (0.85) | |
| Return On Capital Employed | (1.02) | (1.07) | |
| Return On Assets | (0.81) | (0.85) | |
| Return On Equity | (0.96) | (1.01) |
Management Efficiency
GlycoMimetics has return on total asset (ROA) of (0.5925) % which means that it has lost $0.5925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0449) %, meaning that it created substantial loss on money invested by shareholders. GlycoMimetics' management efficiency ratios could be used to measure how well GlycoMimetics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 23, 2024, Return On Tangible Assets is expected to decline to -0.85. In addition to that, Return On Capital Employed is expected to decline to -1.07. At present, GlycoMimetics' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 1.1 M, whereas Other Assets are forecasted to decline to 0.95.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.61 | 0.58 | |
| Tangible Book Value Per Share | 0.61 | 0.58 | |
| Enterprise Value Over EBITDA | (2.77) | (2.91) | |
| Price Book Value Ratio | 3.89 | 1.98 | |
| Enterprise Value Multiple | (2.77) | (2.91) | |
| Price Fair Value | 3.89 | 1.98 | |
| Enterprise Value | 108.5 M | 66.5 M |
The strategic vision of GlycoMimetics management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Operating Margin -4.1 K | Beta 1.842 | Return On Assets (0.59) | Return On Equity (1.04) |
Technical Drivers
As of the 23rd of November, GlycoMimetics retains the Risk Adjusted Performance of 0.0791, downside deviation of 7.15, and Market Risk Adjusted Performance of (1.02). GlycoMimetics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.GlycoMimetics Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GlycoMimetics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GlycoMimetics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GlycoMimetics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GlycoMimetics insiders, such as employees or executives, is commonly permitted as long as it does not rely on GlycoMimetics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GlycoMimetics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GlycoMimetics Outstanding Bonds
GlycoMimetics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GlycoMimetics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GlycoMimetics bonds can be classified according to their maturity, which is the date when GlycoMimetics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
GlycoMimetics Predictive Daily Indicators
GlycoMimetics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GlycoMimetics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 75697.49 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.33 | |||
| Day Typical Price | 0.33 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 54.56 |
GlycoMimetics Forecast Models
GlycoMimetics' time-series forecasting models are one of many GlycoMimetics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GlycoMimetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GlycoMimetics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GlycoMimetics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GlycoMimetics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GlycoMimetics. By using and applying GlycoMimetics Stock analysis, traders can create a robust methodology for identifying GlycoMimetics entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | -3.7 K | -3.5 K | |
| Operating Profit Margin | -3.9 K | -3.7 K | |
| Net Loss | -3.7 K | -3.5 K | |
| Gross Profit Margin | (14.33) | (15.05) |
Current GlycoMimetics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GlycoMimetics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GlycoMimetics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 5.5 | Strong Buy | 1 | Odds |
Most GlycoMimetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GlycoMimetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GlycoMimetics, talking to its executives and customers, or listening to GlycoMimetics conference calls.
GlycoMimetics Stock Analysis Indicators
GlycoMimetics stock analysis indicators help investors evaluate how GlycoMimetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading GlycoMimetics shares will generate the highest return on investment. By understating and applying GlycoMimetics stock analysis, traders can identify GlycoMimetics position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 47.9 M | |
| Common Stock Shares Outstanding | 63.3 M | |
| Total Stockholder Equity | 38.4 M | |
| Property Plant And Equipment Net | 767.8 K | |
| Cash And Short Term Investments | 41.8 M | |
| Cash | 41.8 M | |
| Accounts Payable | 868.1 K | |
| Net Debt | -41 M | |
| 50 Day M A | 0.2448 | |
| Total Current Liabilities | 6.8 M | |
| Other Operating Expenses | 39.3 M | |
| Non Current Assets Total | 1.5 M | |
| Non Currrent Assets Other | 757.9 K | |
| Stock Based Compensation | 3.6 M |
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |